Filing status
- Accounts due
- 31 July 2027
- Last accounts
- 31 October 2025
- Conf. stmt due
- 2 January 2027
- Last conf. stmt
- 19 December 2025
Exigent Therapeutics Limited
- Incorporated
- 20 December 2023 (2 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- David Hoffmann
- Accounts type
- Small
- Region
- East of England
- Address
- The Cambridge Partnership Dorothy Hodgkin Bldg Babraham Research CampusBabrahamCambridgeCB22 3FH
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 19 April 2024
Italian
Born February 1985 (41)
Hoffmann, David, Dr
Director · Appointed 20 December 2023
Austrian
Born November 1990
Officer history (1 former)
19 April 2024
19 April 2024
Resigned Haining, Alexander William Mackay, Dr as Director
20 December 2023
Appointed Hoffmann, David, Dr as Director
20 December 2023
Appointed Haining, Alexander William Mackay, Dr as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
24 April 2024
Ceased David Hoffmann — Owns 25–50% of shares
24 April 2024
Ceased Alexander William Mackay Haining — Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 19 December 2025 | Confirmation statement with updates | 19 December 2025 | 4 | |
| 16 September 2025 | Statement of capital following an allotment of shares | 3 | ||
| 11 March 2025 | Accounts for a small company | 31 October 2024 | 6 | |
| 3 February 2025 | Statement of capital following an allotment of shares | 3 | ||
| 20 December 2024 | Confirmation statement with updates | 19 December 2024 | 4 |
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →